TipRanks
Advertisement
Advertisement

DE:5GH Stock Latest News

Guardant Health price target raised to $220 from $200 at Barclays
The FlyGuardant Health price target raised to $220 from $200 at Barclays
1d ago
GH
Guardant Health reports COSMOS study published in Cancer Research Communications
PremiumThe Fly
Guardant Health reports COSMOS study published in Cancer Research Communications
3d ago
GH
Guardant Health price target raised to $200 from $190 at Guggenheim
PremiumThe Fly
Guardant Health price target raised to $200 from $190 at Guggenheim
7d ago
GH
Grail panel votes ‘closer than we expected,’ says BTIG
PremiumThe Fly
Grail panel votes ‘closer than we expected,’ says BTIG
14d ago
GH
ABT
Craig-Hallum sees potential for confusion after CMS fee schedule
PremiumThe Fly
Craig-Hallum sees potential for confusion after CMS fee schedule
16d ago
GH
NEO
Guardant Health assumed with a Buy at UBS
PremiumThe FlyGuardant Health assumed with a Buy at UBS
29d ago
GH
Guardant Health initiated with a Buy at Rothschild & Co Redburn
Premium
The Fly
Guardant Health initiated with a Buy at Rothschild & Co Redburn
1M ago
GH
Guardant Health: FDA Companion Dx Approval for Camizestrant Validates Longitudinal Liquid Biopsy and Supports Buy Rating
Premium
Ratings
Guardant Health: FDA Companion Dx Approval for Camizestrant Validates Longitudinal Liquid Biopsy and Supports Buy Rating
1M ago
GH
Guardant announces FDA approval of Guardant360 CDx as companion diagnostic
PremiumThe Fly
Guardant announces FDA approval of Guardant360 CDx as companion diagnostic
1M ago
GH
AZN
Guardant Health management to meet with Piper Sandler
PremiumThe Fly
Guardant Health management to meet with Piper Sandler
1M ago
GH
Elevance update guidelines cover Freenome CRC test, says Guggenheim
PremiumThe Fly
Elevance update guidelines cover Freenome CRC test, says Guggenheim
1M ago
GH
ELV
Guardant Health’s Shield Blood test covered by Carelon Health Services
PremiumThe Fly
Guardant Health’s Shield Blood test covered by Carelon Health Services
1M ago
GH
Guardant Health: Patent Ruling Seen as Manageable Overhang, Analyst Maintains Buy Rating on Favorable Risk–Reward
PremiumRatingsGuardant Health: Patent Ruling Seen as Manageable Overhang, Analyst Maintains Buy Rating on Favorable Risk–Reward
1M ago
GH
Guardant Health to appeal federal district court judgment in TwinStrand case
Premium
The Fly
Guardant Health to appeal federal district court judgment in TwinStrand case
1M ago
GH
Guardant Health price target raised to $185 from $175 at Morgan Stanley
Premium
The Fly
Guardant Health price target raised to $185 from $175 at Morgan Stanley
2M ago
GH
Guardant Health price target raised to $195 from $170 at Stephens
PremiumThe Fly
Guardant Health price target raised to $195 from $170 at Stephens
2M ago
GH
Guardant Health price target raised to $193 from $135 at Piper Sandler
PremiumThe Fly
Guardant Health price target raised to $193 from $135 at Piper Sandler
2M ago
GH
Guardant Health: Buy Rating Reiterated as Strong Q2 Results, Raised 2026 Outlook Support Unchanged $205 Price Target
PremiumRatings
Guardant Health: Buy Rating Reiterated as Strong Q2 Results, Raised 2026 Outlook Support Unchanged $205 Price Target
2M ago
GH
Guardant Health price target raised to $180 from $130 at Stifel
PremiumThe Fly
Guardant Health price target raised to $180 from $130 at Stifel
2M ago
GH
Guardant Health Earnings Call Highlights Aggressive Growth
PremiumCompany AnnouncementsGuardant Health Earnings Call Highlights Aggressive Growth
2M ago
GH
Guardant Health price target raised to $200 from $185 at RBC Capital
Premium
The Fly
Guardant Health price target raised to $200 from $185 at RBC Capital
2M ago
GH
Guardant Health price target raised to $210 from $200 at TD Cowen
Premium
The Fly
Guardant Health price target raised to $210 from $200 at TD Cowen
2M ago
GH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >